Articles for tag: depression, DMT, medication, psychiatry, research, risk, treatment

The Clinical Viability of Tryptamine-Based Pharmacotherapy for Major Depressive and Mood Disorders

The field of mental health treatment is witnessing a surge of interest in psychedelic compounds, and Dimethyltryptamine (DMT) is at the forefront of this movement. However, for those following the headlines, it is essential to understand the current status: DMT-based medicines are not yet approved or commercially available. Research into these powerful compounds, particularly the ultra-short-acting analogue 5-MeO-DMT, is still in the mid-stage of clinical testing (Phase 2).   Despite being unapproved, the research is moving quickly. One leading candidate, ...